LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,690,476 | -11.6% | 145,067 | +14.0% | 0.00% | -33.3% |
| Q3 2022 | $10,958,961 | +0.9% | 127,267 | +4.5% | 0.00% | 0.0% |
| Q2 2022 | $10,864,587 | -23.4% | 121,773 | -3.4% | 0.00% | 0.0% |
| Q1 2022 | $14,182,852 | -25.0% | 126,081 | +3.0% | 0.00% | -25.0% |
| Q4 2021 | $18,915,000 | +41.7% | 122,456 | +27.8% | 0.00% | +33.3% |
| Q3 2021 | $13,345,000 | +86.6% | 95,790 | +75.7% | 0.00% | +50.0% |
| Q2 2021 | $7,152,000 | -59.2% | 54,513 | -52.6% | 0.00% | -50.0% |
| Q1 2021 | $17,546,000 | +31.0% | 115,091 | -14.6% | 0.00% | +33.3% |
| Q4 2020 | $13,396,000 | +3.7% | 134,704 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $12,922,000 | -36.8% | 135,563 | -25.8% | 0.00% | -50.0% |
| Q2 2020 | $20,444,000 | +32.3% | 182,782 | -14.0% | 0.01% | 0.0% |
| Q1 2020 | $15,452,000 | -34.7% | 212,481 | -6.3% | 0.01% | -14.3% |
| Q4 2019 | $23,646,000 | +0.8% | 226,729 | -3.8% | 0.01% | 0.0% |
| Q3 2019 | $23,465,000 | -12.8% | 235,737 | 0.0% | 0.01% | -12.5% |
| Q2 2019 | $26,910,000 | -9.2% | 235,737 | 0.0% | 0.01% | -20.0% |
| Q1 2019 | $29,635,000 | -7.4% | 235,737 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $31,990,000 | -47.7% | 235,737 | +5.8% | 0.01% | -40.0% |
| Q3 2018 | $61,135,000 | +41.6% | 222,721 | +6.8% | 0.02% | +33.3% |
| Q2 2018 | $43,184,000 | +33.4% | 208,449 | +6.3% | 0.02% | +25.0% |
| Q1 2018 | $32,374,000 | +34.2% | 196,017 | +11.3% | 0.01% | +33.3% |
| Q4 2017 | $24,116,000 | +12.4% | 176,117 | +11.8% | 0.01% | +12.5% |
| Q3 2017 | $21,452,000 | +12.1% | 157,565 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $19,128,000 | +17.3% | 157,565 | +2.3% | 0.01% | +14.3% |
| Q1 2017 | $16,301,000 | -16.4% | 154,014 | -19.7% | 0.01% | -22.2% |
| Q4 2016 | $19,500,000 | +4.2% | 191,907 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $18,707,000 | -12.2% | 191,907 | +7.5% | 0.01% | -10.0% |
| Q2 2016 | $21,297,000 | +29.0% | 178,565 | +15.8% | 0.01% | +25.0% |
| Q1 2016 | $16,510,000 | -1.2% | 154,165 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $16,715,000 | +26.6% | 154,165 | 0.0% | 0.01% | +14.3% |
| Q3 2015 | $13,204,000 | +109.7% | 154,165 | +147.0% | 0.01% | +133.3% |
| Q2 2015 | $6,298,000 | +111.9% | 62,417 | +61.9% | 0.00% | +200.0% |
| Q1 2015 | $2,972,000 | +44.9% | 38,543 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,051,000 | – | 38,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |